FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205060984> ?p ?o ?g. }

• W3205060984 abstract "Abstract Introduction Vascular endothelial growth factor (VEGF) inhibitors target the formation of new blood vessels required for growth and metastatic spread of a malignant tumor. Although this is an effective anticancer treatment, many patients develop cardiovascular side effects such as hypertension, requiring dose reduction or early termination of treatment. In animals, VEGF inhibitor-induced hypertension is salt-sensitive. Aim To prospectively study whether salt restriction can prevent or attenuate the rise in blood pressure in response to anti-cancer treatment with VEGF inhibitors. Method This is a single centre prospective open-label intervention study. Patients are eligible when treated with a VEGF inhibitor according to standard of care and developing hypertension or a blood pressure rises of 20 mmHg or more during the first treatment cycle. A salt restricted diet (&lt;4 grams/day) including provided salt-less bread is started during the off-treatment period under guidance of a specialized dietitian. The primary endpoint is mean difference in blood pressure rise between the treatment cycle with and the treatment cycle without salt restriction. We aim for a total of 16 patients with a blood pressure rise of at least 20mmHg and/or development of hypertension undergoing the intervention. Results Between 28 November 2019 and 25 March 2021, 45 patients gave informed consent. Fourteen patients developed hypertension and/or a blood pressure rise of at least 20 mmHg after three- four weeks of treatment making them eligible for the intervention. In 10 patients, salt restriction was the only intervention to reduce the blood pressure rise during the following treatment cycle, leading to a reduction in blood pressure rise of 17 mmHg (10 vs 27 mmHg; p&lt;0.001). In four patients antihypertensive treatment was started during the first treatment cycle due to blood pressure rise above 170 mmHg. Salt restriction did not appear to have an important further blood pressure lowering effect, although in one patient the antihypertensive treatment was interrupted during the stop week and salt restriction was sufficient to limit the blood pressure rise in the second cycle. Importantly, the intervention was well tolerated and most patients continued salt restriction after the study finished. Conclusion Applying salt restriction might be an effective and well tolerated intervention to decrease blood pressure rise during treated with VEGF inhibitors. More importantly, this gives important information about the pathogenesis. Further studies of collected blood and 24h urine samples will allow conclusions on the role of endothelin-1, the renin aldosterone system and prostacyclins. FUNDunding Acknowledgement Type of funding sources: Foundation. Main funding source(s): De Merel (Charity aiming for research directly benefiting patients; yearly award, success rate ∼30% “Stichting De Merel”)" @default.
• W3205060984 created "2021-10-25" @default.
• W3205060984 creator A5000285493 @default.
• W3205060984 creator A5020185139 @default.
• W3205060984 creator A5027968873 @default.
• W3205060984 creator A5030911238 @default.
• W3205060984 creator A5031821028 @default.
• W3205060984 creator A5045236213 @default.
• W3205060984 creator A5046295598 @default.
• W3205060984 creator A5049156968 @default.
• W3205060984 creator A5049350040 @default.
• W3205060984 creator A5050202217 @default.
• W3205060984 creator A5065885053 @default.
• W3205060984 creator A5071612016 @default.
• W3205060984 date "2021-10-01" @default.
• W3205060984 modified "2023-10-18" @default.
• W3205060984 title "Prevention of VEGF inhibitor-induced toxicity by salt restriction: the SUN-SALT study" @default.
• W3205060984 doi "https://doi.org/10.1093/eurheartj/ehab724.2929" @default.
• W3205060984 hasPublicationYear "2021" @default.
• W3205060984 type Work @default.
• W3205060984 sameAs 3205060984 @default.
• W3205060984 citedByCount "0" @default.
• W3205060984 crossrefType "journal-article" @default.
• W3205060984 hasAuthorship W3205060984A5000285493 @default.
• W3205060984 hasAuthorship W3205060984A5020185139 @default.
• W3205060984 hasAuthorship W3205060984A5027968873 @default.
• W3205060984 hasAuthorship W3205060984A5030911238 @default.
• W3205060984 hasAuthorship W3205060984A5031821028 @default.
• W3205060984 hasAuthorship W3205060984A5045236213 @default.
• W3205060984 hasAuthorship W3205060984A5046295598 @default.
• W3205060984 hasAuthorship W3205060984A5049156968 @default.
• W3205060984 hasAuthorship W3205060984A5049350040 @default.
• W3205060984 hasAuthorship W3205060984A5050202217 @default.
• W3205060984 hasAuthorship W3205060984A5065885053 @default.
• W3205060984 hasAuthorship W3205060984A5071612016 @default.
• W3205060984 hasBestOaLocation W32050609841 @default.
• W3205060984 hasConcept C126322002 @default.
• W3205060984 hasConcept C141071460 @default.
• W3205060984 hasConcept C167734588 @default.
• W3205060984 hasConcept C203092338 @default.
• W3205060984 hasConcept C2777025900 @default.
• W3205060984 hasConcept C535046627 @default.
• W3205060984 hasConcept C71924100 @default.
• W3205060984 hasConcept C84393581 @default.
• W3205060984 hasConceptScore W3205060984C126322002 @default.
• W3205060984 hasConceptScore W3205060984C141071460 @default.
• W3205060984 hasConceptScore W3205060984C167734588 @default.
• W3205060984 hasConceptScore W3205060984C203092338 @default.
• W3205060984 hasConceptScore W3205060984C2777025900 @default.
• W3205060984 hasConceptScore W3205060984C535046627 @default.
• W3205060984 hasConceptScore W3205060984C71924100 @default.
• W3205060984 hasConceptScore W3205060984C84393581 @default.
• W3205060984 hasIssue "Supplement_1" @default.
• W3205060984 hasLocation W32050609841 @default.
• W3205060984 hasOpenAccess W3205060984 @default.
• W3205060984 hasPrimaryLocation W32050609841 @default.
• W3205060984 hasRelatedWork W2002120878 @default.
• W3205060984 hasRelatedWork W2003938723 @default.
• W3205060984 hasRelatedWork W2047967234 @default.
• W3205060984 hasRelatedWork W2118496982 @default.
• W3205060984 hasRelatedWork W2364998975 @default.
• W3205060984 hasRelatedWork W2369162477 @default.
• W3205060984 hasRelatedWork W2439875401 @default.
• W3205060984 hasRelatedWork W4238867864 @default.
• W3205060984 hasRelatedWork W2519357708 @default.
• W3205060984 hasRelatedWork W2525756941 @default.
• W3205060984 hasVolume "42" @default.
• W3205060984 isParatext "false" @default.
• W3205060984 isRetracted "false" @default.
• W3205060984 magId "3205060984" @default.
• W3205060984 workType "article" @default.